Mercado de diagnóstico de accidentes cerebrovasculares en América del Norte: tendencias de la industria y pronóstico hasta 2028

Análisis y perspectivas del mercado: mercado de diagnóstico de accidentes cerebrovasculares en América del Norte

Se espera que el mercado de diagnóstico de accidentes cerebrovasculares de América del Norte gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 6,6% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 2097,75 millones para 2028. El crecimiento de la I+D en la industria de la salud y un aumento en el gasto en atención médica son los principales impulsores que se prevé que impulsen la demanda del mercado en el período de pronóstico. Por el contrario, las retiradas de productos están restringiendo el mercado.

Un accidente cerebrovascular se produce cuando el suministro de sangre al cerebro disminuye o se bloquea por completo, lo que impide que el tejido cerebral reciba oxígeno y nutrientes. Existen varios tipos de dispositivos de diagnóstico que se utilizan para detectar un accidente cerebrovascular y sus síntomas iniciales, por ejemplo, la tomografía computarizada (TC), la angiografía por tomografía computarizada (ATC), la resonancia magnética (RM), la angiografía por resonancia magnética (ARM), la ecografía Doppler transcraneal y otros.

La creciente incidencia de accidentes cerebrovasculares y enfermedades cardiovasculares y neurológicas ha aumentado la demanda de diagnósticos de accidentes cerebrovasculares en los países en desarrollo. Además, el aumento del gasto en atención médica está impulsando el crecimiento del mercado. Por otro lado, el alto costo del diagnóstico puede obstaculizar el crecimiento del mercado. La presencia de actores del mercado y los lanzamientos de nuevos productos brindan una oportunidad. Sin embargo, la falta de profesionales capacitados puede suponer un desafío para el mercado.

El informe de mercado de diagnóstico de accidentes cerebrovasculares proporciona detalles sobre la participación de mercado, los nuevos desarrollos, el impacto de los actores del mercado nacional y localizado, análisis de oportunidades en términos de segmentos de ingresos emergentes, cambios en las regulaciones del mercado, aprobaciones de productos , decisiones estratégicas, lanzamientos de productos, expansiones geográficas e innovaciones tecnológicas en el mercado. Para comprender el análisis y el escenario del mercado, contáctenos para obtener un resumen analítico. Nuestro equipo lo ayudará a crear una solución de impacto en los ingresos para lograr su objetivo deseado.

Alcance y tamaño del mercado de diagnóstico de accidentes cerebrovasculares en América del Norte

The North America stroke diagnostics market is segmented on the basis of severity, type, application, end user, distribution channel, and stage. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of severity, the North America stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market, with a surge in the increasing R&D activities.
• On the basis of type, the North America stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), other. In 2021, the computed tomography (CT scan) segment is expected to dominate the market with the increasing government initiatives to provide better-advanced devices.
• On the basis of application, the North America stroke diagnostics market is segmented into ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS). In 2021, ischemic stroke is expected to dominate the market with the increasing product launch by major market players.
• On the basis of end-users, the North America stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the market with the presence of skilled professionals and staff.
• On the basis of distribution channel, the North America stroke diagnostics market is segmented into direct tender, third party distributor, and others. In 2021, direct tender is expected to dominate the market due to the growing number of patients with stroke.
• On the basis of stage, the North America stroke diagnostics market is segmented into pre-operative, peri-operative, and post-operative. In 2021, pre-operative is expected to dominate the market due to the increasing advancement in product development.

Stroke Diagnostics Market Country Level Analysis

The stroke diagnostics market is analyzed, and market size information is provided on the basis of severity, type, application, end users, distribution channel, and stage.

The countries covered in the North America stroke diagnostics market report are the U.S., Canada, and Mexico.

The stroke diagnostics segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing research development for enhancing the product quality. The U.S is expected to lead the growth of the North America stroke diagnostics market, and the direct tender segment is anticipated to dominate due to the rising incidence of disease in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Increase in Advancement and Technology for New Product Development is Boosting the Market Growth of Stroke diagnostics

The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the stroke diagnostics technology, and changes in regulatory scenarios with their support for the stroke diagnostics market. The data is available for the historic period 2011 to 2019.

Competitive Landscape and Stroke Diagnostics Market Share Analysis

Stroke diagnostics market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.

The major companies which are dealing in the North America stroke diagnostics market are Siemens, Koninklijke Philips N.V., Stryker, Hologic, Inc., ESAOTE SPA, Medtron AG, Shenzhen Anke High-Tech CO., Ltd, Aspect Imaging Ltd, Siemens, FONAR Corp, FUJIFILM Holdings Corporation, General Electric Company, ALPINION MEDICAL SYSTEMS Co., Ltd., Ltd, TERASON DIVISION TERATECH CORPORATION, Analogic Corporation, Carestream Health, IMRIS, Deerfield Imaging Inc., Canon Inc., SAMSUNG, SternMed GmbH among others.

Many product launches and agreements are also initiated by companies worldwide, which also accelerates the stroke diagnostics market.

For instance,

• In February 2021, Koninklijke Philips N.V  announced that they had successfully completed the acquisition of BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. The acquisition has added the new technological wearable sensing products to their product pipeline
• In September 2021, SAMSUNG announced that they had completed the acquisition of the company in HARMAN. The acquisition has increased the company's product portfolio and technological advancement

La colaboración, el lanzamiento de productos, la expansión comercial, los premios y reconocimientos, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de diagnóstico de accidentes cerebrovasculares, lo que también proporciona el beneficio para que la organización mejore su oferta de diagnóstico de accidentes cerebrovasculares.

SKU-66145